Sandoz Accuses United Therapeutics Of Blocking Generic Remodulin

 
• By Penelope MacRae

A Sandoz lawsuit has accused United Therapeutics of trying to illegally block sales of the first US generic version of Remodulin.

Road block
Sandoz Says United Therapeutics Has Blocked Its Path On Generic Treprostinil • Source: Shutterstock

More from Legal & IP

More from Generics Bulletin